SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Nov 6, 2017
Document Date
Sep 30, 2017
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS INC